BEAM

BEAM THERAPEUTICS INC

Healthcare | Mid Cap

-$0.85

EPS Forecast

$18.31

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-07-01

Proximilar's AI forecasts

EPS Forecast:

-$0.85

Revenue Forecast:

$18.31

EPS Surprise Forecast:

$0.016

Revenue Surprise Forecast:

-$3

Post-release price volatility - High

Post-release Overnight Move:

±8.3%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

55%

Probability of beating revenue consensus:

42%

Probability of beating both EPS & revs consensus:

29%

Probability of missing both EPS & revs consensus:

32%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-4

Beta (β)

Forward Looking Beta (β):

2.00

Earnings volatility

EPS standard deviation:

$0.57

Revenue standard deviation:

$22

As % of share price:

2.27% EXTREME UNCERTAINTY

As % of market cap:

0.86% MEDIUM

Confidence intervals and percentiles

EPS 95th %ile:

-$0.11

Revenue 95th %ile:

$46

EPS 75th %ile:

-$0.66

Revenue 75th %ile:

$26

EPS 25th %ile:

-$1.02

Revenue 25th %ile:

$12

EPS 5th %ile:

-$1.49

Revenue 5th %ile:

-$5

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

40% MEDIUM

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

100% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$21

Bid-ask per Share:

$0.05